Cargando…

Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types

SIMPLE SUMMARY: Our study evaluated the use of the intestinal microbiome as a prognostic marker that seems to modulate response to immune checkpoint inhibitor (ICI) treatment in patients with late-stage non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), and metastatic melanoma. BiomeOne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Irina, Hochmair, Maximilian Johannes, Schmidinger, Manuela, Absenger, Gudrun, Pichler, Martin, Nguyen, Van Anh, Richtig, Erika, Rainer, Barbara Margaretha, Ay, Leyla, Jansen, Christian, Pacífico, Cátia, Knabl, Alexander, Sladek, Barbara, Gasche, Nikolaus, Valipour, Arschang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339964/ https://www.ncbi.nlm.nih.gov/pubmed/37444378 http://dx.doi.org/10.3390/cancers15133268

Ejemplares similares

Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study
por: Illini, Oliver, et al.
Publicado: (2022)

Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis
por: Hochmair, Maximilian J., et al.
Publicado: (2020)

Effectiveness of Outpatient Pulmonary Rehabilitation in Patients with Surgically Resected Lung Cancer: A Retrospective Real-World Analysis
por: Illini, Oliver, et al.
Publicado: (2022)

Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
por: Richtig, Georg, et al.
Publicado: (2017)

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung
por: Brcic, Luka, et al.
Publicado: (2018)

Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review
por: Huf, Waltraud Elisabeth, et al.
Publicado: (2023)

Modern Bronchoscopic Treatment Options for Patients with Chronic Bronchitis
por: Mayr, Anna Katharina, et al.
Publicado: (2023)

“Nitrogen Wash-Out” in Non-Hypoxaemic Patients with Spontaneous Pneumothorax: A Narrative Review
por: Grasmuk-Siegl, Erwin, et al.
Publicado: (2023)

Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing—A Prospective Feasibility Study
por: Berger, Marina, et al.
Publicado: (2021)

Chronic obstructive pulmonary disease phenotypes: imprint on pharmacological and non-pharmacological therapy
por: Bakeer, Mostafa, et al.
Publicado: (2020)

Prediction of Response in Melanoma Therapy by Systemic Inflammatory Response – One Size Fits Not All
por: Richtig, Georg, et al.
Publicado: (2017)

Atypical enteropathogenic E. coli are associated with disease activity in ulcerative colitis
por: Baumgartner, Maximilian, et al.
Publicado: (2022)

Swiss Experience in Therapy With Dual Bronchodilation in Chronic Obstructive Pulmonary Disease in Relation to Self-Reported Physical Functionality
por: Spielmanns, Marc, et al.
Publicado: (2021)

Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients
por: Holzknecht, Arnulf, et al.
Publicado: (2022)

Assessment of Patient Experiences with Respimat(®) in Everyday Clinical Practice
por: Taube, Christian, et al.
Publicado: (2020)

Therapeutic Success in Swiss COPD Patients Receiving Dual Bronchodilation Therapy as COPD Maintenance Treatment
por: Spielmanns, Marc, et al.
Publicado: (2022)

Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
por: Totschnig, David, et al.
Publicado: (2022)

Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening program
por: Brezina, Stefanie, et al.
Publicado: (2023)

Nintedanib plus Docetaxel after Immune Checkpoint Inhibitor Failure in Patients with Advanced Non-Small-Cell Lung Cancer: A Case Series
por: Hochmair, Maximilian Johannes, et al.
Publicado: (2022)

Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer
por: Hamilton, Gerhard, et al.
Publicado: (2015)

Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2018)

ASCO update: lung cancer
por: Absenger, Gudrun, et al.
Publicado: (2017)

Chronisch-obstruktive Lungenerkrankung 2021 – die richtige Therapie für den richtigen Patienten
por: Olschewski, Horst, et al.
Publicado: (2021)

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program
por: Illini, Oliver, et al.
Publicado: (2021)

Organizing pneumonia following Covid19 pneumonia
por: Funk, Georg-Christian, et al.
Publicado: (2021)

Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study
por: Richtig, Georg, et al.
Publicado: (2018)

Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells
por: Plangger, Adelina, et al.
Publicado: (2021)

Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease
por: Hochmair, Maximilian
Publicado: (2018)

Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan‐cancer study
por: Barth, Dominik A., et al.
Publicado: (2022)

Resistance to chemoimmunotherapy in non-small-cell lung cancer
por: Hochmair, Maximilian Johannes
Publicado: (2020)

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study
por: Riedl, Jakob M., et al.
Publicado: (2020)

Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD
por: Urban, Matthias Helmut, et al.
Publicado: (2017)

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)
por: Slebos, Dirk-Jan, et al.
Publicado: (2020)

Determinants of community members’ willingness to donate stool for faecal microbiota transplantation
por: Hyde, Melissa K., et al.
Publicado: (2020)

Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells
por: STICKLER, SANDRA, et al.
Publicado: (2023)

Rapidly Processed Stool Swabs Approximate Stool Microbiota Profiles
por: Bokulich, Nicholas A., et al.
Publicado: (2019)

Stool Consistency: Looking Beyond the Bristol Stool Form Scale
por: Vork, Lisa, et al.
Publicado: (2019)

Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study
por: Barth, Dominik A., et al.
Publicado: (2022)

Soluble ST2 and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease—A 10-Year Cohort Study
por: Urban, Matthias H., et al.
Publicado: (2021)

Awareness of predatory journals and open access among medical oncologists: results of an online survey
por: Richtig, Georg, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rrfj0t2vl2achko3870diku0no